In MCL with classic histology, patients with EZH2+ MCL had a poorer outcome compared with patients with EZH2-negative MCL (median, 4.6 and 9.6 years, respectively, p < 0.001) (Fig. 3C). The gene discussed is EZH2; the disease is mantle cell lymphoma.